• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1600070 注射用重组抗HER2人源化单克隆抗体组合物 B-002 Lyophilized Biological Products(1) New Drug Application 2017-02-13 上海医药集团股份有限公司 Shanghai Pharmaceuticals Holding Co Ltd Certificate Issued 2017-09-27 view